Energenesis Competitors

6657 Stock

59.00 1.40 2.43%

Energenesis Biomedical competes with Taiwan Semiconductor, Hon Hai, MediaTek, Chunghwa Telecom, and Formosa Petrochemical; as well as few others. Analyzing Energenesis Biomedical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Energenesis Biomedical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Energenesis Biomedical competition on your existing holdings.

Specify up to 10 symbols:

Energenesis Biomedical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Energenesis Biomedical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Energenesis and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Energenesis Biomedical does not affect the price movement of the other competitor.

	2330	2317	2454	2412	6505	2308	2882	2303	1303	1301
2330		0.91	0.89	-0.42	-0.38	0.7	0.93	-0.6	0.01	-0.13	2330
2317	0.91		0.88	-0.61	-0.41	0.65	0.87	-0.69	-0.07	-0.18	2317
2454	0.89	0.88		-0.49	-0.36	0.66	0.89	-0.61	0.01	-0.12	2454
2412	-0.42	-0.61	-0.49		0.4	-0.12	-0.33	0.56	0.47	0.48	2412
6505	-0.38	-0.41	-0.36	0.4		-0.09	-0.23	0.87	0.77	0.88	6505
2308	0.7	0.65	0.66	-0.12	-0.09		0.66	-0.25	0.14	0.05	2308
2882	0.93	0.87	0.89	-0.33	-0.23	0.66		-0.51	0.19	0.06	2882
2303	-0.6	-0.69	-0.61	0.56	0.87	-0.25	-0.51		0.53	0.67	2303
1303	0.01	-0.07	0.01	0.47	0.77	0.14	0.19	0.53		0.96	1303
1301	-0.13	-0.18	-0.12	0.48	0.88	0.05	0.06	0.67	0.96		1301
	2330	2317	2454	2412	6505	2308	2882	2303	1303	1301

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

High positive correlations

1301	+ 0.96	1303
2882	+ 0.93	2330
2317	+ 0.91	2330
2454	+ 0.89	2330
2882	+ 0.89	2454
2454	+ 0.88	2317

High negative correlations

2303	- 0.69	2317
2303	- 0.61	2454
2412	- 0.61	2317
2303	- 0.6	2330
2303	- 0.51	2882
2412	- 0.49	2454

Risk-Adjusted Indicators

There is a big difference between Energenesis Stock performing well and Energenesis Biomedical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Energenesis Biomedical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
2330	1.36	0.15	0.04	0.61	1.59	(1.64)	2.97	(2.34)	9.09
2317	1.49	0.04	0.00	0.17	1.83	(1.56)	3.69	(2.96)	8.59
2454	1.85	0.06	0.00	0.23	2.22	(2.22)	4.05	(2.62)	11.11
2412	0.39	(0.02)	0.00	(0.24)	0.00	0.00	0.82	(1.19)	2.43
6505	1.46	(0.51)	0.00	(1.19)	0.00	0.00	2.89	(3.51)	9.39
2308	1.39	(0.08)	0.00	(0.05)	0.00	0.00	2.84	(3.46)	11.60
2882	1.00	0.12	0.01	2.66	1.12	(1.10)	1.92	(1.57)	5.19
2303	0.93	(0.38)	0.00	(0.64)	0.00	0.00	1.35	(2.20)	5.44
1303	1.37	(0.25)	0.00	(0.38)	0.00	0.00	2.85	(2.84)	10.09
1301	1.54	(0.33)	0.00	(1.26)	0.00	0.00	4.33	(3.23)	10.13

Unable to evaluate fundamental data of Energenesis Biomedical Co at this time. Please try again later

All Fundamental Data

Energenesis Biomedical Competitive Analysis

The better you understand Energenesis Biomedical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Energenesis Biomedical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Energenesis Biomedical's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	6657	2330	2317	2454	2412	6505	2308	2882	2303	1303
	2.43 59.00 Energenesis	1.42 1,070 Taiwan	2.29 201.00 Hon	0.38 1,320 MediaTek	0.81 124.50 Chunghwa	1.71 40.25 Formosa	1.02 395.00 Delta	0.15 69.00 Cathay	0.78 44.45 United	2.40 38.70 Nan
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady
Market Performance (90 Days Performance)	Good	Good	OK	OK	Weak	Very Weak	Insignificant	Good	Very Weak	Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Unknown	Low	Low	Low	Low	Low	Low	Below Average	Low	Low
Current Valuation (Equity Enterprise Value)	Fairly Valued	Over Valued	Fairly Valued	Fairly Valued	Fairly Valued	Over Valued	Fairly Valued	Fairly Valued	Under Valued	Fairly Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Buy	Strong Buy	Strong Buy	Strong Buy	Buy	Strong Buy	Strong Buy	Strong Hold	Strong Buy	Strong Buy
Current Ratio		1.88	1.74	1.85	1.66	4.62	1.62	0.6	2.44	1.71
Net Asset		4.96 T	3.91 T	660.88 B	513.07 B	458.76 B	365.11 B	11.59 T	464.43 B	668.7 B
Profit Margin		0.45	0.0223	0.22	0.17	0.0382	0.0855	0.13	0.31	0.13
EBITDA		753.4 B	291.01 B	137.21 B	46.84 B	75.36 B	53.07 B	(235.56 B)	110.75 B	124.76 B
Operating Margin		0.5	0.0278	0.23	0.22	0.0324	0.1	-0.42	0.37	0.12
Current Valuation		11.82 T	1.29 T	1.06 T	875.55 B	755.81 B	761.27 B	(1.27 T)	422.35 B	641.46 B
Price To Book		4.55	0.97	2.69	2.34	2.38	4.22	1.96	1.76	1.52
Retained Earnings		959.08 B	736.98 B	121.96 B	134.47 B	128.41 B	50.02 B	N/A	50.91 B	175.07 B
Current Asset		812.49 B	1.59 T	229.12 B	84.11 B	240.35 B	129.91 B	N/A	101.92 B	205.3 B
Five Year Return		3.07	3.36	4.7	4.72	3.81	3.59	4.29	3.89	5.42
Beta		1.26	0.64	1.2	0.0156	0.41	1.06	0.61	1.32	0.6
Number Of Employees		67	826.61 K	52	134	46	38	57.1 K	20 K	57
Shares Outstanding		25.93 B	13.86 B	1.59 B	7.76 B	9.53 B	2.6 B	14.67 B	12.48 B	7.93 B
Cash Flow From Operations		1.61 T	(98.21 B)	47.09 B	74.86 B	35.53 B	28.32 B	72.52 B	90.35 B	78.88 B
Annual Yield		0.0202	0.0512	0.0987	0.0406	0.0458	0.0187	0.0803	0.0591	0.1
Total Debt		610.07 B	275.6 B	827.66 M	28.58 B	29.2 B	43.91 B	272.56 B	39.83 B	86.11 B
Return On Equity		0.4	0.0994	0.27	0.0942	0.0933	0.17	0.12	0.29	0.14
Z Score		13.8	4.0	N/A	18.0	17.2	10.2	1.2	9.0	3.6
Return On Asset		0.16	0.0284	0.12	0.0592	0.0385	0.0605	-0.0129	0.13	0.0432
Book Value Per Share		113.61	104.53	277.57	47.94	34.27	70.06	21.23	27.14	48.48
Current Liabilities		235.89 B	870.7 B	134.15 B	54.05 B	57.61 B	69.33 B	N/A	41.63 B	73.73 B
Total Asset		4.96 T	3.91 T	660.88 B	513.07 B	458.76 B	365.11 B	11.59 T	464.43 B	668.7 B
Debt To Equity		0.21	50.4	24.6	2.9	6.4	22.2	0.59	0.32	0.39
Target Price		609.49	128.2	768.87	112.2	77.13	332.19	49.2	50.22	68.0
Last Dividend Paid		N/A	5.2	N/A	N/A	3.8	5.5	3.5	N/A	7.5
Shares Owned By Institutions		42.0	26.64	48.34	24.38	2.43	37.64	20.27	26.69	13.09
Market Capitalization		14.13 T	1.41 T	1.13 T	884.35 B	794.47 B	763.68 B	639.58 B	629.08 B	598.78 B
Price To Earning		28.3	10.2	26.38	22.46	19.89	15.18	10.43	19.08	16.55
Price To Earnings To Growth		0.82	0.7	0.84	-45.87	-1.46	1.48	1.99	1.43	-2.09
Price To Sales		5.88	0.21	1.83	4.0	0.94	2.08	0.94	2.03	1.48
Net Income		1.02 T	139.32 B	111.42 B	36.52 B	49.4 B	26.8 B	139.51 B	55.78 B	81.3 B
Earnings Per Share		39.2	10.31	81.56	4.71	3.35	11.88	5.11	6.36	6.33
Shares Owned By Insiders		N/A	12.56	8.17	41.21	87.55	25.93	36.05	9.0	38.12
Revenue		2.26 T	5.99 T	493.41 B	216.74 B	620.06 B	314.67 B	621.86 B	213.01 B	411.67 B
Working Capital		576.6 B	718.29 B	94.96 B	30.06 B	182.75 B	60.57 B	N/A	60.29 B	131.56 B
Cash And Equivalents		870.84 B	927.31 B	215.52 B	43.02 B	104.17 B	45.64 B	591.17 B	149.97 B	110.86 B
Cash Per Share		33.58	66.9	136.43	5.55	10.94	17.57	47.06	12.09	13.98
Gross Profit		1.35 T	362.13 B	270.9 B	46.84 B	65.78 B	90.21 B	325.74 B	125.76 B	103.85 B
Day Typical Price	58.33	1065.0	199.83	1316.67	124.17	40.53	393.33	68.8	44.3	39.1
Accumulation Distribution	10920.51	486425.0	1.1 M	72824.74	39768.67	151435.0	42500.09	134671.0	523915.0	322511.0
Daily Balance Of Power	0.7	1.0	1.0	0.25	1.0	(0.67)	0.8	0.1667	(0.78)	(0.79)
Period Momentum Indicator	1.4	15.0	4.5	5.0	1.0	(0.70)	4.0	0.1	(0.35)	(0.95)
Rate Of Daily Change	1.02	1.01	1.02	1.0	1.01	0.98	1.01	1.0	0.99	0.98
Day Median Price	58.0	1062.5	199.25	1315.0	124.0	40.67	392.5	68.7	44.23	39.3
Price Action Indicator	1.7	15.0	4.0	7.5	1.0	(0.78)	4.5	0.35	0.05	(1.07)
Relative Strength Index	50.04	47.05	48.33	51.58	47.45	33.83	44.82	47.89	25.69	45.43
Coefficient Of Variation	1003.37	956.23	1695.06	2041.63	(12,091)	(430.62)	(14,138)	960.07	(381.43)	(1,056)
Mean Deviation	0.9941	1.36	1.49	1.85	0.388	1.46	1.39	0.9971	0.9279	1.37
Jensen Alpha	0.1084	0.1512	0.0407	0.0593	(0.02)	(0.51)	(0.08)	0.1169	(0.38)	(0.25)
Total Risk Alpha	(0.06)	(0.07)	(0.16)	(0.22)	(0.09)	(0.73)	(0.29)	(0.05)	(0.49)	(0.46)
Sortino Ratio	0.0331	0.0399	2.0E-4	0.0016	N/A	N/A	N/A	0.0145	N/A	N/A
Downside Variance	1.35	3.88	4.32	6.74	N/A	N/A	N/A	1.59	N/A	N/A
Standard Deviation	1.52	1.84	1.93	2.4	0.5559	1.97	1.95	1.26	1.21	1.93
Kurtosis	4.48	1.35	(0.27)	0.6773	0.5661	1.0	2.31	(0.08)	0.4583	3.07
Potential Upside	3.34	2.97	3.69	4.05	0.8163	2.89	2.84	1.92	1.35	2.85
Treynor Ratio	0.438	0.6117	0.17	0.2303	(0.24)	(1.19)	(0.05)	2.66	(0.64)	(0.38)
Maximum Drawdown	7.92	9.09	8.59	11.11	2.43	9.39	11.6	5.19	5.44	10.09
Variance	2.32	3.37	3.72	5.76	0.309	3.87	3.81	1.6	1.46	3.74
Market Risk Adjusted Performance	0.448	0.6217	0.18	0.2403	(0.23)	(1.18)	(0.04)	2.67	(0.63)	(0.37)
Risk Adjusted Performance	0.081	0.0856	0.0511	0.0442	(0.01)	(0.17)	7.0E-4	0.0834	(0.20)	(0.07)
Skewness	1.35	(0.08)	0.1106	(0.36)	(0.54)	0.0306	0.0088	0.0138	0.0485	0.323
Semi Deviation	0.9414	1.59	1.83	2.22	N/A	N/A	N/A	1.12	N/A	N/A
Information Ratio	0.0253	0.0428	2.0E-4	0.0017	(0.21)	(0.29)	(0.07)	0.0144	(0.36)	(0.15)
Value At Risk	(1.53)	(2.34)	(2.96)	(2.62)	(1.19)	(3.51)	(3.46)	(1.57)	(2.20)	(2.84)
Expected Short fall	(1.41)	(1.64)	(1.56)	(2.22)	N/A	N/A	N/A	(1.10)	N/A	N/A
Downside Deviation	1.16	1.97	2.08	2.6	N/A	N/A	N/A	1.26	N/A	N/A
Semi Variance	0.8862	2.54	3.36	4.93	N/A	N/A	N/A	1.25	N/A	N/A

Energenesis Biomedical Competition Performance Charts

Five steps to successful analysis of Energenesis Biomedical Competition

Energenesis Biomedical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Energenesis Biomedical in relation to its competition. Energenesis Biomedical's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Energenesis Biomedical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Energenesis Biomedical's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Energenesis Biomedical, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Energenesis Biomedical position

In addition to having Energenesis Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Advertising Thematic Idea Now

Advertising

Companies specializing in advertising, marketing and advertising services. The Advertising theme has 37 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Advertising Theme or any other thematic opportunities.

View All Next

Launch

Additional Tools for Energenesis Stock Analysis

When running Energenesis Biomedical's price analysis, check to measure Energenesis Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Energenesis Biomedical is operating at the current time. Most of Energenesis Biomedical's value examination focuses on studying past and present price action to predict the probability of Energenesis Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Energenesis Biomedical's price. Additionally, you may evaluate how the addition of Energenesis Biomedical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC